Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer.
Staley A, Tucker K, Yin Y, Zhang X, Fan Y, Zhang Y, Fang Z, Sun W, Suo H, Zhao X, Zhao Z, Prabhu VV, Allen JE, Zhou C, Bae-Jump VL.
Staley A, et al. Among authors: zhao z, zhao x.
Am J Cancer Res. 2021 Nov 15;11(11):5374-5387. eCollection 2021.
Am J Cancer Res. 2021.
PMID: 34873466
Free PMC article.